Improving the quality of life of patients with breast cancer-related lymphedema by lymphaticovenous anastomosis (LVA): A randomized controlled trial - LYMPH-trial

Medisch Universitair Ziekenhuis Maastricht0 个研究点目标入组 100 人开始时间: 待定最近更新: 2024年4月15日

试验速览

暂无简介。

•- Women over 18 years old
•- Treated for early stage breast cancer and who underwent a sentinel lymph node
•biopsy, axillary lymph node dissection or axillary radiotherapy
•- Early stage lymphedema of the arm (ISL classification stage I/IIa; pitting
•edema without fibrosis) with viable lymphatic vessels as determined by
•indocyanin green (ICG-) lymphography
•- Already received at least three months of complex decongestive therapy
•(currently in the maintenance phase) prior to inclusion
•- Primary breast cancer
•- Unilateral lymphedema
•- Informed consent

•- Male sex
•- Late stage lymphedema of the arm (ISL classification IIb/III lymphedema) with
•evident fat deposition and/or fibrosis
•- History of earlier lymph reconstruction efforts
•- Recurrent breast cancer
•- Distant breast cancer metastases
•- Bilateral lymphedema
•- Primary congenital lymphedema
•- Non-viable lymphatic system as determined by ICG lymphography

发起方

Medisch Universitair Ziekenhuis Maastricht